HLTHQ — Cue Health Income Statement
0.000.00%
Last trade - 00:00- $0.00m
- -$79.73m
- $70.94m
- 13
- 82
- 28
- 36
Annual income statement for Cue Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6.63 | 23 | 618 | 483 | 70.9 |
| Cost of Revenue | |||||
| Gross Profit | 6.63 | 8 | 342 | 154 | -56.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 27.4 | 68.7 | 430 | 689 | 445 |
| Operating Profit | -20.8 | -45.7 | 188 | -206 | -374 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -20.6 | -47.4 | 119 | -204 | -369 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -20.6 | -47.4 | 86.4 | -194 | -373 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -20.6 | -47.4 | 86.4 | -194 | -373 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -20.6 | -47.4 | 86.4 | -194 | -373 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.143 | -0.325 | 0.599 | -1.3 | -2.11 |
| Dividends per Share |